Merck's once-weekly diabetes drug approved in Japan
September 28, 2015 at 08:17 AM EDT
Sept 28 (Reuters) - Merck & CO said its Type 2 diabetes drug had been approved in Japan, marking the first approval for the once-weekly drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.